Log in

OTCMKTS:VRTTViatar CTC Solutions Stock Price, Forecast & News

$0.01
0.00 (0.00 %)
(As of 05/26/2020)
Add
Compare
Today's Range
$0.01
Now: $0.01
$0.05
50-Day Range
$0.01
MA: $0.06
$0.07
52-Week Range
$0.01
Now: $0.01
$0.07
Volume37,000 shs
Average Volume1,850 shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
Beta-0.81
Viatar CTC Solutions Inc., a biotechnology company, focuses on developing and marketing cancer molecular diagnostics and cancer therapy products in the United States. Its products include Viatar collection system for molecular analysis that collects and purifies circulating tumor cells (CTCs) for DNA sequencing and other genetic analysis technologies used primarily for research; and Viatar therapeutic oncopheresis system to remove CTCs from a patient's blood as a new cancer therapy for metastatic disease. The company was formerly known as Vizio Medical Devices LLC and changed its name to Viatar CTC Solutions Inc. in February 2014. Viatar CTC Solutions Inc. was founded in 2007 and is headquartered in Lowell, Massachusetts.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 2.7Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.54 out of 5 stars


Industry, Sector and Symbol

Industry Surgical & medical instruments
Sub-IndustryN/A
SectorMedical
Current SymbolOTCMKTS:VRTT
CUSIPN/A
Phone617-299-6590

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

Employees8
Next Earnings DateN/A
OptionableNot Optionable

Receive VRTT News and Ratings via Email

Sign-up to receive the latest news and ratings for VRTT and its competitors with MarketBeat's FREE daily newsletter.

Viatar CTC Solutions (OTCMKTS:VRTT) Frequently Asked Questions

How has Viatar CTC Solutions' stock been impacted by COVID-19 (Coronavirus)?

Viatar CTC Solutions' stock was trading at $0.07 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, VRTT stock has decreased by 84.3% and is now trading at $0.0110. View which stocks have been most impacted by Coronavirus.

Has Viatar CTC Solutions been receiving favorable news coverage?

Headlines about VRTT stock have been trending extremely negative on Friday, InfoTrie Sentiment reports. The research group identifies positive and negative media coverage by reviewing more than six thousand news and blog sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Viatar CTC Solutions earned a daily sentiment score of -5.0 on InfoTrie's scale. They also gave headlines about the company a news buzz of 0.0 out of 10, indicating that recent media coverage is extremely unlikely to have an impact on the company's share price in the immediate future. View the latest news aboutViatar CTC Solutions.

Who are some of Viatar CTC Solutions' key competitors?

Who are Viatar CTC Solutions' key executives?

Viatar CTC Solutions' management team includes the following people:
  • Mr. Stephen Keaney, VP of R&D (Age 57)
  • Mr. Brian McCarthy Ph.D., VP of Bus. Devel.

What is Viatar CTC Solutions' stock symbol?

Viatar CTC Solutions trades on the OTCMKTS under the ticker symbol "VRTT."

How do I buy shares of Viatar CTC Solutions?

Shares of VRTT can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Viatar CTC Solutions' stock price today?

One share of VRTT stock can currently be purchased for approximately $0.01.

What is Viatar CTC Solutions' official website?

The official website for Viatar CTC Solutions is www.viatarctcsolutions.com.

How can I contact Viatar CTC Solutions?

Viatar CTC Solutions' mailing address is 116 John Street Suite 10, Lowell MA, 01852. The company can be reached via phone at 617-299-6590 or via email at [email protected]

This page was last updated on 6/5/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.